Del, Pfizer, Care Technologies Lice Removal Claims Challenged by FTC
This article was originally published in The Tan Sheet
Executive Summary
Lice treatment ad claims for OTC pediculicides marketed by Del Pharmaceuticals, Pfizer and Care Technologies will be modified to convey the limitations of the products' effectiveness under proposed consent orders announced by the Federal Trade Commission Sept. 18.